WO2010003319A8 - 红霉素的盐的水合物及其制备方法和用途 - Google Patents

红霉素的盐的水合物及其制备方法和用途 Download PDF

Info

Publication number
WO2010003319A8
WO2010003319A8 PCT/CN2009/000787 CN2009000787W WO2010003319A8 WO 2010003319 A8 WO2010003319 A8 WO 2010003319A8 CN 2009000787 W CN2009000787 W CN 2009000787W WO 2010003319 A8 WO2010003319 A8 WO 2010003319A8
Authority
WO
WIPO (PCT)
Prior art keywords
acid
hydrates
preparation
gram
macrolide derivatives
Prior art date
Application number
PCT/CN2009/000787
Other languages
English (en)
French (fr)
Other versions
WO2010003319A1 (zh
Inventor
刘力
Original Assignee
Liu Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liu Li filed Critical Liu Li
Priority to BRPI0910785A priority Critical patent/BRPI0910785A2/pt
Priority to RU2011104715/04A priority patent/RU2510659C2/ru
Priority to EP09793794.0A priority patent/EP2301945B1/en
Priority to AU2009267689A priority patent/AU2009267689B2/en
Priority to US13/003,397 priority patent/US8470787B2/en
Priority to JP2011516951A priority patent/JP2011527292A/ja
Publication of WO2010003319A1 publication Critical patent/WO2010003319A1/zh
Publication of WO2010003319A8 publication Critical patent/WO2010003319A8/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
PCT/CN2009/000787 2008-07-10 2009-07-10 红霉素的盐的水合物及其制备方法和用途 WO2010003319A1 (zh)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BRPI0910785A BRPI0910785A2 (pt) 2008-07-10 2009-07-10 sal de eritromicina hidratado, composição farmacêutica, processo para preparar um sal de eritromicina hidratado e uso de sal de eritromicina hidratado
RU2011104715/04A RU2510659C2 (ru) 2008-07-10 2009-07-10 Гидраты солей эритромицина, их получение и применение
EP09793794.0A EP2301945B1 (en) 2008-07-10 2009-07-10 Hydrates of erythromycin salts, the preparation and the use thereof
AU2009267689A AU2009267689B2 (en) 2008-07-10 2009-07-10 Hydrates of erythromycin salts, the preparation and the use thereof
US13/003,397 US8470787B2 (en) 2008-07-10 2009-07-10 Hydrates of erythromycin salts, preparation and use thereof
JP2011516951A JP2011527292A (ja) 2008-07-10 2009-07-10 エリスロマイシン塩の水和物、その製造方法及び使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2008100483834A CN101624412B (zh) 2008-07-10 2008-07-10 大环内酯类衍生物及其制备和用途
CN200810048383.4 2008-07-10

Publications (2)

Publication Number Publication Date
WO2010003319A1 WO2010003319A1 (zh) 2010-01-14
WO2010003319A8 true WO2010003319A8 (zh) 2011-02-24

Family

ID=41506672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2009/000787 WO2010003319A1 (zh) 2008-07-10 2009-07-10 红霉素的盐的水合物及其制备方法和用途

Country Status (10)

Country Link
US (1) US8470787B2 (zh)
EP (1) EP2301945B1 (zh)
JP (1) JP2011527292A (zh)
KR (1) KR101626506B1 (zh)
CN (1) CN101624412B (zh)
AU (1) AU2009267689B2 (zh)
BR (1) BRPI0910785A2 (zh)
MY (1) MY160483A (zh)
RU (1) RU2510659C2 (zh)
WO (1) WO2010003319A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101830835A (zh) * 2010-03-26 2010-09-15 刘力 丹皮酚磺酸钠结晶水合物及其制备方法和用途
FR2966843B1 (fr) * 2010-11-03 2013-04-26 Roquette Freres Procede de decontamination d'hydrolysats d'amidon pour la preparation de polymeres de glucose destines a la dialyse peritoneale
EP2749564B1 (en) 2011-08-26 2016-10-12 Hec Pharm Co., Ltd Preparation process of erythromycin thiocyanate
US9636376B2 (en) 2012-09-11 2017-05-02 Innopharma, Inc. Stable compositions of peptide epoxy ketones
CN102911228A (zh) * 2012-11-02 2013-02-06 伊犁川宁生物技术有限公司 一种硫氰酸红霉素的精制和制备方法
CN103483407B (zh) * 2013-10-10 2015-11-18 宁夏启元药业有限公司 一种硫氰酸红霉素萃取结晶用复合溶媒及萃取结晶方法
CN104447918A (zh) * 2014-11-27 2015-03-25 广东东阳光药业有限公司 制备克拉霉素杂质c的方法
CN104819622B (zh) * 2015-05-19 2018-02-13 湖南科伦制药有限公司 一种乳糖酸红霉素的冻干方法
RU2600924C1 (ru) * 2015-06-19 2016-10-27 Общество с ограниченной ответственностью "Научно-исследовательский центр "Полимерные соединения" Способ получения фармацевтической композиции эритромицина
CN113150044B (zh) * 2021-04-28 2022-03-18 宜昌东阳光生化制药有限公司 一种硫氰酸红霉素的纯化方法
CN115381771A (zh) * 2022-08-30 2022-11-25 四川博大金点生物技术有限公司 一种泰乐菌素注射液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2761859A (en) * 1953-01-14 1956-09-04 Abbott Lab Aqueous soluble salts of erythromycin
US2791531A (en) * 1953-10-22 1957-05-07 Lilly Co Eli Erythromycin thiocyanate and compositions containing same
GB1013837A (en) * 1962-12-07 1965-12-22 Pierrel Spa Erythromycin salts and esters
GB1250045A (en) * 1969-01-15 1971-10-20 Pierrel Spa A new water soluble derivative of erythromycin
US3637654A (en) * 1969-04-03 1972-01-25 Abbott Lab Purification of erythromycin thiocyanate
US4137397A (en) * 1976-06-01 1979-01-30 Registrar, Jadavpur University Erythromycin aldobionates
US4340582A (en) * 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CN1249309A (zh) * 1998-09-29 2000-04-05 南京泛太化工医药研究所 大环内酯类抗生素的龙胆酸盐
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
US6642276B2 (en) * 2001-10-01 2003-11-04 M/S Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
JP2005522470A (ja) * 2002-04-03 2005-07-28 ハンミ ファーム． シーオー．， エルティーディー． アジスロマイシンの製造方法及びそれに用いられる９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシンＡの結晶性水和物
CN1850045A (zh) * 2006-05-22 2006-10-25 济南康泉医药科技有限公司 一种含大环内酯抗生素的缓释制剂

Also Published As

Publication number Publication date
AU2009267689B2 (en) 2014-01-16
CN101624412B (zh) 2012-07-04
JP2011527292A (ja) 2011-10-27
KR20110050447A (ko) 2011-05-13
RU2510659C2 (ru) 2014-04-10
BRPI0910785A2 (pt) 2018-01-09
RU2011104715A (ru) 2012-08-20
KR101626506B1 (ko) 2016-06-01
US8470787B2 (en) 2013-06-25
WO2010003319A1 (zh) 2010-01-14
EP2301945A4 (en) 2011-12-14
EP2301945A1 (en) 2011-03-30
EP2301945B1 (en) 2014-10-15
CN101624412A (zh) 2010-01-13
AU2009267689A1 (en) 2010-01-14
US20110184158A1 (en) 2011-07-28
MY160483A (en) 2017-03-15

Similar Documents

Publication Publication Date Title
WO2010003319A8 (zh) 红霉素的盐的水合物及其制备方法和用途
WO2007069020A3 (en) N-hydroxyamide derivatives possessing antibacterial activity
MX2020001453A (es) Compuestos de dihidroazol antiparasiticos y composiciones que comprenden los mismos.
NO20073849L (no) Indolderivater for behandling av virale infeksjoner
CY1117193T1 (el) Φαρμακευτικη συνθεση για θεραπεια ή αποτροπη γλαυκωματος
WO2010038081A3 (en) 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
CU20110083A7 (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
NO20092033L (no) Nye forbindelser
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
JP2009520038A5 (zh)
WO2006113552A8 (en) Cyanoarylamines
BR112012014858A2 (pt) agente antiplaqueta
MXPA06001552A (es) Quinazolinil nitrofuranos halogenados como agentes antibacterianos.
WO2007126900A3 (en) Antifungal agents
EP3216798A3 (en) Ketolide compounds
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
MX2012006026A (es) Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus.
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NZ613956A (en) C-4" position substituted macrolide derivative
US10052309B2 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
BRPI1007414A2 (pt) derivados de tiadiazóis e de oxadiazóis, o respectivo preparo e a respectiva aplicação em terapêutica
WO2008155666A3 (en) Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
MY156304A (en) 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09793794

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2011516951

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009267689

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2009793794

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 450/DELNP/2011

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2009267689

Country of ref document: AU

Date of ref document: 20090710

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20117003091

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011104715

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 13003397

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: PI0910785

Country of ref document: BR

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE A PROCURACAO APRESENTADA NAO POSSUI DATA. SALIENTA-SE QUE TAL DOCUMENTO TEM QUE PREVER COMO OUTORGADO O PROCURADOR ORIGINAL DA ENTRADA NA FASE NACIONAL.

ENP Entry into the national phase

Ref document number: PI0910785

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20110110